Professor Peter Rossing is a clinician researcher devoted to
complications in diabetes with a focus on renal and cardiovascular
complications. He holds a specialist degree in internal medicine and
endocrinology and is Chief physician and manager of the Steno Diabetes
Center research team dedicated to the research of micro-and
macrovascular complications of diabetes.
Professor Rossing has investigated key features of the pathophysiology of the diabetic kidney at different stages in epidemiological studies. He has identified several markers for development of diabetic nephropathy, making it possible to predict the individual risk. He has been involved in several intervention studies in patients with overt diabetic nephropathy aiming at improving the prognosis.
Professor Rossing is a coordinator of the EU FP7 project PRIORITY, which aims to test if urinary proteomics can be used to stratify prevention of renal complications in type 2 diabetes, and the Novo Nordisk Foundation grant PROTON, which aims at personalising prevention of diabetic nephropathy.